2Keane WF,Lyle PA.Recent advances in management of type 2 diabetes and nephropathy.Lessons from the RENAAL study.Am J kidney Dis,2003,1:s22-s25.
3Lewis EJ,Hunsick LG,Clarke WR.Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.N Engl J Med,2001,345:851-860.
4Parving HH,Lehnert H.The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.N Engl J Med,2001,345:870-878.
5植田太郎 井林博.糖尿病性神经障害とPGE1[J].最新医学,1984,39:516-516.
6顾勇 等.前列腺素及其肾脏作用[J].国外医学：泌尿系统分册,1988,4:701-701.
7林善钦.肾脏疾病慢性进展的发病机制[J].中华肾脏病杂志,1987,3:34-34.
8Schlondorff D.Renal prostaglandln synthesis sites of production and spesific action of prostaglandins.Ami Med 1986,81:1.
